| Scott Gottlieb |
|Born||June 11, 1972|
East Brunswick, New Jersey, U.S.
|Alma mater||Wesleyan University, Mount Sinai Medical Center|
Food and Drug Administration leader, then over to Pfizer.
Scott Gottlieb is an American physician and investor who served as the 23rd commissioner of the Food and Drug Administration (FDA) from 2017 until April 2019. He is presently a resident fellow at the conservative think tank theAmerican Enterprise Institute (AEI), a partner at the venture capital firm New Enterprise Associates (NEA), a member of the board of directors of drug maker Pfizer, Inc, and a member of the board of directors of Illumina, Inc.
National security agencies to stop the next pandemic
Historically, the national security agencies wanted to avoid public health issues. And the public health community didn’t want the clandestine services anywhere near its mission out of concern that everyone with a white coat would be perceived to be a spy. Covid-19 showed us that the intelligence agencies need to be involved in gathering information about emerging infections around the world. This information is held by soft targets.